| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AAZTA5/AAZTA5-TOC: synthesis and radiochemical evaluation with 68Ga, 44Sc and 177Lu
|
Sinnes, Jean-Philippe
|
|
2019
|
4 |
1 |
p. 1-10
|
artikel
|
| 2 |
Auger electrons for cancer therapy – a review
|
Ku, Anthony
|
|
2019
|
4 |
1 |
p. 1-36
|
artikel
|
| 3 |
Automated preparation of clinical grade [68Ga]Ga-DOTA-CP04, a cholecystokinin-2 receptor agonist, using iPHASE MultiSyn synthesis platform
|
Haskali, Mohammad B.
|
|
2019
|
4 |
1 |
p. 1-10
|
artikel
|
| 4 |
Automated synthesis of [11C]L-glutamine on Synthra HCN plus synthesis module
|
Padakanti, Prashanth K.
|
|
2019
|
4 |
1 |
p. 1-9
|
artikel
|
| 5 |
[11C]Carbon monoxide: advances in production and application to PET radiotracer development over the past 15 years
|
Taddei, Carlotta
|
|
2019
|
4 |
1 |
p. 1-31
|
artikel
|
| 6 |
Clinical-grade N-(4-[18F]fluorobenzoyl)-interleukin-2 for PET imaging of activated T-cells in humans
|
Veen, Elly L. van der
|
|
2019
|
4 |
1 |
p. 1-15
|
artikel
|
| 7 |
Comparison of desferrioxamine and NODAGA for the gallium-68 labeling of exendin-4
|
Kaeppeli, Simon A. M.
|
|
2019
|
4 |
1 |
p. 1-11
|
artikel
|
| 8 |
Current radiotracers to image neurodegenerative diseases
|
Tiepolt, Solveig
|
|
2019
|
4 |
1 |
p. 1-23
|
artikel
|
| 9 |
Development and implementation of ISAR, a new synthesis platform for radiopharmaceutical production
|
Frank, Christopher
|
|
2019
|
4 |
1 |
p. 1-18
|
artikel
|
| 10 |
Endorsement of International Consensus Radiochemistry Nomenclature Guidelines
|
Elsinga, Philip
|
|
2019
|
4 |
1 |
p. 1
|
artikel
|
| 11 |
Ethanol effects on 68Ga-radiolabelling efficacy and radiolysis in automated synthesis utilizing NaCl post-processing
|
Meisenheimer, Michael
|
|
2019
|
4 |
1 |
p. 1-10
|
artikel
|
| 12 |
Evaluation of polydentate picolinic acid chelating ligands and an α-melanocyte-stimulating hormone derivative for targeted alpha therapy using ISOL-produced 225Ac
|
Ramogida, Caterina F.
|
|
2019
|
4 |
1 |
p. 1-20
|
artikel
|
| 13 |
Fast and efficient copper-mediated 18F-fluorination of arylstannanes, aryl boronic acids, and aryl boronic esters without azeotropic drying
|
Lahdenpohja, Salla Orvokki
|
|
2019
|
4 |
1 |
p. 1-11
|
artikel
|
| 14 |
Fully-automated radiosynthesis of the amyloid tracer [11C] PiB via direct [11C]CO2 fixation-reduction
|
Buccino, Pablo
|
|
2019
|
4 |
1 |
p. 1-15
|
artikel
|
| 15 |
Have you looked for “stranger things” in your automated PET dose dispensing system? A process and operators qualification scheme
|
Martin, Tristan
|
|
2019
|
4 |
1 |
p. 1-8
|
artikel
|
| 16 |
Improved synthesis of [18F] fallypride and characterization of a Huntington’s disease mouse model, zQ175DN KI, using longitudinal PET imaging of D2/D3 receptors
|
Huhtala, Tuulia
|
|
2019
|
4 |
1 |
p. 1-10
|
artikel
|
| 17 |
Improved synthesis of SV2A targeting radiotracer [11C]UCB-J
|
Rokka, Johanna
|
|
|
4 |
1 |
p. 1-10
|
artikel
|
| 18 |
Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers
|
Bauckneht, Matteo
|
|
2019
|
4 |
1 |
p. 1-25
|
artikel
|
| 19 |
Open letter to journal editors on: International Consensus Radiochemistry Nomenclature Guidelines
|
Coenen, Heinz H.
|
|
2019
|
4 |
1 |
p. 1-5
|
artikel
|
| 20 |
Pitfalls and solutions of the fully-automated radiosynthesis of [11C]metoclopramide
|
Pichler, Verena
|
|
|
4 |
1 |
p. 1-14
|
artikel
|
| 21 |
Production and characterization of no-carrier-added 161Tb as an alternative to the clinically-applied 177Lu for radionuclide therapy
|
Gracheva, Nadezda
|
|
2019
|
4 |
1 |
p. 1-16
|
artikel
|
| 22 |
Radiochemical and analytical aspects of inter-institutional quality control measurements on radiopharmaceuticals
|
Blois, Erik de
|
|
2019
|
4 |
1 |
p. 1-13
|
artikel
|
| 23 |
Radionuclide generator-based production of therapeutic 177Lu from its long-lived isomer 177mLu
|
Bhardwaj, Rupali
|
|
2019
|
4 |
1 |
p. 1-12
|
artikel
|
| 24 |
Radionuclides: medicinal products or rather starting materials?
|
Neels, Oliver
|
|
2019
|
4 |
1 |
p. 1-4
|
artikel
|
| 25 |
Radiosynthesis and in vivo evaluation of 11C-labeled BMS-193885 and its desmethyl analog as PET tracers for neuropeptide Y1 receptors
|
Kawamura, Kazunori
|
|
2019
|
4 |
1 |
p. 1-13
|
artikel
|
| 26 |
Synthesis of a benzoxazinthione derivative of tanaproget and pharmacological evaluation for PET imaging of PR expression
|
Allott, Louis
|
|
2019
|
4 |
1 |
p. 1-20
|
artikel
|
| 27 |
Targeting of activated fibroblasts for imaging and therapy
|
Lindner, Thomas
|
|
2019
|
4 |
1 |
p. 1-15
|
artikel
|
| 28 |
The new Regulation on clinical trials in relation to radiopharmaceuticals: when and how will it be implemented?
|
Peñuelas, Iván
|
|
2019
|
4 |
1 |
p. 1-5
|
artikel
|
| 29 |
The various therapeutic applications of the medical isotope holmium-166: a narrative review
|
Klaassen, Nienke J. M.
|
|
2019
|
4 |
1 |
p. 1-26
|
artikel
|
| 30 |
Tracers for non-invasive radionuclide imaging of immune checkpoint expression in cancer
|
Wierstra, Peter
|
|
2019
|
4 |
1 |
p. 1-20
|
artikel
|
| 31 |
US and EU radiopharmaceutical diagnostic and therapeutic nonclinical study requirements for clinical trials authorizations and marketing authorizations
|
Schwarz, Sally W.
|
|
2019
|
4 |
1 |
p. 1-5
|
artikel
|
Tijdschrift beschrijving